Papillomatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials

Avelumab for People With Recurrent Respiratory Papillomatosis
Conditions:   Recurrent Respiratory Papillomatosis;   Juvenile Laryngeal Papilloma;   Laryngeal Papilloma, Recurrent;   Respiratory Papillomatosis;   Human Papilloma Virus Intervention:   Drug: Avelumab Sponsor:   National Cancer Institute (NCI) Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2016 Category: Research Source Type: clinical trials

Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Condition:   Recurrent Respiratory Papillomatosis Intervention:   Drug: EF-022 (Modified Vitamin D Binding Protein Macrophage Activator) Sponsor:   Efranat Ltd. Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2016 Category: Research Source Type: clinical trials